Charles Schwab’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.42M Sell
137,129
-9,839
-7% -$669K ﹤0.01% 2191
2026
Q1
$11M Sell
146,968
-920
-0.6% -$75.4K ﹤0.01% 2049
2025
Q4
$11.5M Buy
147,888
+5,207
+4% +$423K ﹤0.01% 2064
2025
Q3
$12.1M Buy
142,681
+3,613
+3% +$289K ﹤0.01% 2022
2025
Q2
$10.9M Buy
139,068
+4,570
+3% +$337K ﹤0.01% 1969
2025
Q1
$9.73M Sell
134,498
-7,169
-5% -$602K ﹤0.01% 1963
2024
Q4
$12.6M Sell
141,667
-7,234
-5% -$645K ﹤0.01% 1913
2024
Q3
$12.6M Sell
148,901
-6,140
-4% -$545K ﹤0.01% 1921
2024
Q2
$14.3M Sell
155,041
-3,609
-2% -$365K ﹤0.01% 1862
2024
Q1
$17.9M Buy
158,650
+6,551
+4% +$654K ﹤0.01% 1679
2023
Q4
$14.2M Buy
152,099
+2,063
+1% +$182K ﹤0.01% 1809
2023
Q3
$13.8M Buy
150,036
+8,314
+6% +$893K ﹤0.01% 1733
2023
Q2
$17.2M Buy
141,722
+10,591
+8% +$1.14M ﹤0.01% 1603
2023
Q1
$12.8M Buy
131,131
+1,826
+1% +$174K ﹤0.01% 1747
2022
Q4
$10.5M Buy
129,305
+3,177
+3% +$267K ﹤0.01% 1825
2022
Q3
$9.59M Buy
126,128
+5,349
+4% +$514K ﹤0.01% 1862
2022
Q2
$13.2M Buy
120,779
+2,515
+2% +$267K ﹤0.01% 1680
2022
Q1
$11.8M Buy
118,264
+6,500
+6% +$620K ﹤0.01% 1862
2021
Q4
$10.7M Buy
111,764
+8,722
+8% +$874K ﹤0.01% 1968
2021
Q3
$11.4M Buy
103,042
+6,611
+7% +$753K ﹤0.01% 1928
2021
Q2
$11.2M Buy
96,431
+6,366
+7% +$731K ﹤0.01% 1935
2021
Q1
$9.38M Buy
90,065
+5,526
+7% +$687K ﹤0.01% 1995
2020
Q4
$10.2M Buy
84,539
+502
+0.6% +$50.7K ﹤0.01% 1861
2020
Q3
$7.3M Sell
84,037
-1,774
-2% -$153K ﹤0.01% 1872
2020
Q2
$6.95M Buy
85,811
+6,946
+9% +$507K ﹤0.01% 1866
2020
Q1
$5.44M Buy
78,865
+1,326
+2% +$140K ﹤0.01% 1793
2019
Q4
$8.87M Buy
77,539
+1,420
+2% +$177K ﹤0.01% 1717
2019
Q3
$9.94M Buy
76,119
+1,676
+2% +$218K 0.01% 1609
2019
Q2
$9.13M Buy
74,443
+2,706
+4% +$311K 0.01% 1648
2019
Q1
$7.54M Buy
71,737
+2,856
+4% +$307K ﹤0.01% 1755
2018
Q4
$7.05M Sell
68,881
-519
-0.7% -$57.6K 0.01% 1689
2018
Q3
$8.23M Buy
69,400
+2,895
+4% +$327K 0.01% 1765
2018
Q2
$6.38M Buy
66,505
+1,321
+2% +$123K ﹤0.01% 1870
2018
Q1
$5.3M Buy
65,184
+5,500
+9% +$426K ﹤0.01% 1907
2017
Q4
$4.31M Buy
59,684
+3,174
+6% +$217K ﹤0.01% 1996
2017
Q3
$3.47M Buy
56,510
+2,873
+5% +$175K ﹤0.01% 2065
2017
Q2
$3.24M Buy
53,637
+541
+1% +$34.6K ﹤0.01% 2029
2017
Q1
$3.47M Buy
53,096
+2,490
+5% +$176K ﹤0.01% 1962
2016
Q4
$3.55M Buy
50,606
+2,522
+5% +$160K ﹤0.01% 1920
2016
Q3
$3.02M Buy
48,084
+2,062
+4% +$127K ﹤0.01% 1925
2016
Q2
$2.77M Buy
46,022
+810
+2% +$44.4K ﹤0.01% 1917
2016
Q1
$2.25M Buy
45,212
+899
+2% +$44.7K ﹤0.01% 1992
2015
Q4
$2.38M Buy
44,313
+1,283
+3% +$64.3K ﹤0.01% 1993
2015
Q3
$1.93M Buy
43,030
+7,538
+21% +$376K ﹤0.01% 2083
2015
Q2
$1.94M Buy
35,492
+984
+3% +$48.7K ﹤0.01% 2121
2015
Q1
$1.64M Buy
34,508
+1,392
+4% +$59.2K ﹤0.01% 2166
2014
Q4
$1.39M Sell
33,116
-1,289
-4% -$50.7K ﹤0.01% 2197
2014
Q3
$1.22M Buy
34,405
+714
+2% +$25.2K ﹤0.01% 2212
2014
Q2
$1.15M Sell
33,691
-224
-0.7% -$7.23K ﹤0.01% 2252
2014
Q1
$1.17M Buy
33,915
+840
+3% +$27.9K ﹤0.01% 2211
2013
Q4
$1.17M Buy
33,075
+4,508
+16% +$148K ﹤0.01% 2195
2013
Q3
$908K Buy
28,567
+1,358
+5% +$40.1K ﹤0.01% 2257
2013
Q2
$762K Buy
+27,209
New +$719K ﹤0.01% 2309

Other funds holding USPH

Charles Schwab's USPH Position: Q2 2026 in Review

Charles Schwab reduced its US Physical Therapy (USPH) stake by 6.7% in Q2 2026, selling an estimated $669K and leaving 137,129 shares worth $9.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2191.

Charles Schwab first reported a position in USPH in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.9M in Q1 2024. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Charles Schwab held 137,129 shares of US Physical Therapy worth $9.42M as of Q2 2026.
  • Charles Schwab sold 9,839 US Physical Therapy shares in Q2 2026, an estimated $669K.
  • US Physical Therapy made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2191 holding.
  • Charles Schwab first reported a position in US Physical Therapy in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's US Physical Therapy position peaked at $17.9M in Q1 2024.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.